title: Circulating soluble SR-PSOX/CXCL16 as a biomarker for acute coronary syndrome -comparison with high-sensitivity C-reactive protein.
abstract: OBJECTIVE
  Diagnostic values of soluble SR-PSOX/CXCL16 (sSR-PSOX/CXCL16), a receptor for atherogenic oxidized LDL and a membrane-anchored chemokine for CXCR6-positive lymphocytes, for acute coronary syndrome (ACS) were evaluated..
  
  
  METHODS
  We examined 106 patients undergoing coronary angiography (CAG); 17 patients with ACS and 89 patients without ACS (non-ACS) including stable angina. Circulating sSR-SPOX/CXCL16 was measured in peripheral venous blood by sandwich ELISA.
  
  
  RESULTS
  Age, gender, prevalence of diabetes or hypertension, and serum lipid profiles were not significantly different between ACS and non-ACS. Presence or absence of risk factors, such as diabetes, smoking and hypertension, did not significantly affect circulating sSR-PSOX/CXCL16 levels. Circulating sSR-PSOX/CXCL16 levels were significantly lower in ACS than non-ACS (median: 3.05 versus 3.36 ng/mL, p<0.02). Lipid profiles, high-sensitivity C-reactive protein (hs-CRP), cardiac troponin T (TnT), and soluble LOX-1 (sLOX-1) showed no significant correlation with sSR-PSOX/CXCL16. Receiver-operating characteristic (ROC) curves for ACS detection indicate higher sensitivity and specificity for sSR-PSOX/CXCL16 than hs-CRP. In the TnT-negative and sLOX-1-negative subpopulation, sSR-PSOX/CXCL16 showed similar sensitivity and specificity for ACS; however, hs-CRP showed less sensitivity and specificity for ACS when compared with the whole population.
  
  
  CONCLUSIONS
  sSR-PSOX/CXCL16 is a biomarker for ACS, which would provide additional diagnostic information besides TnT and sLOX-1.
authors.affiliation: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto Univeristy, Japan.
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Mitsuoka
authors.forename: Masako
authors.initials: M
authors.lastname: Toyohara
authors.forename: Noriaki
authors.initials: N
authors.lastname: Kume
authors.forename: Kazutaka
authors.initials: K
authors.lastname: Hayashida
authors.forename: Toshikazu
authors.initials: T
authors.lastname: Jinnai
authors.forename: Masaru
authors.initials: M
authors.lastname: Tanaka
authors.forename: Toru
authors.initials: T
authors.lastname: Kita
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood*; D000368:Aged; D015415:Biomarkers / Q000097:blood*; D002097:C-Reactive Protein / Q000032:analysis*; D000075743:Chemokine CXCL16; D019743:Chemokines, CXC / Q000097:blood*; D017023:Coronary Angiography; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012372:ROC Curve; D051116:Receptors, Scavenger / Q000097:blood*; D012680:Sensitivity and Specificity; D012995:Solubility
chemical_list: D015415:Biomarkers; C423727:CXCL16 protein, human; D000075743:Chemokine CXCL16; D019743:Chemokines, CXC; D051116:Receptors, Scavenger; D002097:C-Reactive Protein